170 related articles for article (PubMed ID: 35596898)
21. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
22. HOTAIR Induces Methylation of PCDH10, a Tumor Suppressor Gene, by Regulating DNMT1 and Sponging with miR-148b in Gastric Adenocarcinoma.
Seo SI; Yoon JH; Byun HJ; Lee SK
Yonsei Med J; 2021 Feb; 62(2):118-128. PubMed ID: 33527791
[TBL] [Abstract][Full Text] [Related]
23. Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancer.
Liu X; Zhang J; Liu L; Jiang Y; Ji J; Yan R; Zhu Z; Yu Y
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2835-2844. PubMed ID: 29802960
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
25. Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma.
Wilop S; van Gemmeren TB; Lentjes MH; van Engeland M; Herman JG; Brümmendorf TH; Jost E; Galm O
Epigenetics; 2011 Aug; 6(8):1047-52. PubMed ID: 21934357
[TBL] [Abstract][Full Text] [Related]
26. SOCS3 promoter hypermethylation is a favorable prognosticator and a novel indicator for G-CIMP-positive GBM patients.
Feng Y; Wang Z; Bao Z; Yan W; You G; Wang Y; Hu H; Zhang W; Zhang Q; Jiang T
PLoS One; 2014; 9(3):e91829. PubMed ID: 24633048
[TBL] [Abstract][Full Text] [Related]
27. Tissue-Specific Down-Regulation of the Long Non-Coding RNAs PCAT18 and LINC01133 in Gastric Cancer Development.
Foroughi K; Amini M; Atashi A; Mahmoodzadeh H; Hamann U; Manoochehri M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518158
[TBL] [Abstract][Full Text] [Related]
28. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect.
Suzuki H; Yamamoto E; Nojima M; Kai M; Yamano HO; Yoshikawa K; Kimura T; Kudo T; Harada E; Sugai T; Takamaru H; Niinuma T; Maruyama R; Yamamoto H; Tokino T; Imai K; Toyota M; Shinomura Y
Carcinogenesis; 2010 Dec; 31(12):2066-73. PubMed ID: 20924086
[TBL] [Abstract][Full Text] [Related]
29. Lower LINE-1 methylation is associated with promoter hypermethylation and distinct molecular features in gastric cancer.
Tahara S; Tahara T; Horiguchi N; Okubo M; Terada T; Yoshida D; Funasaka K; Nakagawa Y; Shibata T; Tsukamoto T; Ohmiya N
Epigenomics; 2019 Nov; 11(15):1651-1659. PubMed ID: 31701771
[No Abstract] [Full Text] [Related]
30. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG
Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497
[TBL] [Abstract][Full Text] [Related]
31. Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders.
Fourouclas N; Li J; Gilby DC; Campbell PJ; Beer PA; Boyd EM; Goodeve AC; Bareford D; Harrison CN; Reilly JT; Green AR; Bench AJ
Haematologica; 2008 Nov; 93(11):1635-44. PubMed ID: 18815196
[TBL] [Abstract][Full Text] [Related]
32. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
Takada H; Wakabayashi N; Dohi O; Yasui K; Sakakura C; Mitsufuji S; Taniwaki M; Yoshikawa T
Cancer Genet Cytogenet; 2010 Feb; 197(1):16-24. PubMed ID: 20113832
[TBL] [Abstract][Full Text] [Related]
33. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.
Yu J; Liang Q; Wang J; Wang K; Gao J; Zhang J; Zeng Y; Chiu PW; Ng EK; Sung JJ
Oncogene; 2017 Jan; 36(2):182-193. PubMed ID: 27212034
[TBL] [Abstract][Full Text] [Related]
34. KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome.
Ma G; Liu H; Hua Q; Wang M; Du M; Lin Y; Ge Y; Gong W; Zhao Q; Qiang F; Tao G; Zhang Z; Chu H
Mol Cancer; 2017 Feb; 16(1):46. PubMed ID: 28231797
[TBL] [Abstract][Full Text] [Related]
35. Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.
Cui H; Wang L; Gong P; Zhao C; Zhang S; Zhang K; Zhou R; Zhao Z; Fan H
PLoS One; 2015; 10(4):e0123926. PubMed ID: 25874772
[TBL] [Abstract][Full Text] [Related]
36. Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer.
Otani K; Dong Y; Li X; Lu J; Zhang N; Xu L; Go MY; Ng EK; Arakawa T; Chan FK; Sung JJ; Yu J
J Pathol; 2014 Nov; 234(3):302-15. PubMed ID: 24931004
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA NALT1-induced gastric cancer invasion and metastasis
Piao HY; Guo S; Wang Y; Zhang J
World J Gastroenterol; 2019 Nov; 25(44):6508-6526. PubMed ID: 31802831
[TBL] [Abstract][Full Text] [Related]
38. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.
Takada H; Imoto I; Tsuda H; Nakanishi Y; Ichikura T; Mochizuki H; Mitsufuji S; Hosoda F; Hirohashi S; Ohki M; Inazawa J
Oncogene; 2005 Dec; 24(54):8051-60. PubMed ID: 16103878
[TBL] [Abstract][Full Text] [Related]
39. ZNF677 downregulation by promoter hypermethylation as a driver event through gastric tumorigenesis.
Bidar N; Rezaei T; Amini M; Jebelli A; Mokhtarzadeh A; Baradaran B
Exp Mol Pathol; 2021 Aug; 121():104663. PubMed ID: 34171355
[TBL] [Abstract][Full Text] [Related]
40. Promoter CpG island hypermethylation and down regulation of XRCC1 gene can augment in the gastric carcinogenesis events.
Nissar B; Kadla SA; Wani KA; Shah IA; Ganai BA
Mol Biol Rep; 2021 Jan; 48(1):405-412. PubMed ID: 33394233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]